Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia.

Enomoto T, Tatara A, Goda M, Nishizato Y, Nishigori K, Kitamura A, Kamada M, Taga S, Hashimoto T, Ikeda K, Fujii Y.

J Pharmacol Exp Ther. 2019 Dec;371(3):692-702. doi: 10.1124/jpet.119.260869. Epub 2019 Oct 2.

PMID:
31578257
2.

Comparison of Levothyroxine Dosing in Patients with and without Heart Failure.

Yang T, Ruegger M, Colavecchia AC, Sadhu A, Patham B, Tatara A.

Endocr Res. 2020 Feb;45(1):50-57. doi: 10.1080/07435800.2019.1645165. Epub 2019 Jul 26.

PMID:
31345070
3.

Evaluating Time to In-Hospital Venous Thromboembolism in Obese Patients.

Cutshall BT, Tatara AW, Upadhyay N, Adeola M, Putney D, Ruegger M.

J Pharm Pract. 2019 Jul 14:897190019847002. doi: 10.1177/0897190019847002. [Epub ahead of print]

PMID:
31303103
4.

Biomaterials-aided mandibular reconstruction using in vivo bioreactors.

Tatara AM, Koons GL, Watson E, Piepergerdes TC, Shah SR, Smith BT, Shum J, Melville JC, Hanna IA, Demian N, Ho T, Ratcliffe A, van den Beucken JJJP, Jansen JA, Wong ME, Mikos AG.

Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6954-6963. doi: 10.1073/pnas.1819246116. Epub 2019 Mar 18.

5.

A murine model of cutaneous aspergillosis for evaluation of biomaterials-based local delivery therapies.

Tatara AM, Watson E, Albert ND, Kontoyiannis PD, Kontoyiannis DP, Mikos AG.

J Biomed Mater Res A. 2019 Sep;107(9):1867-1874. doi: 10.1002/jbm.a.36671. Epub 2019 Apr 7.

PMID:
30882993
6.

Combined Insulin and GLP-1 Receptor Agonists: Simplifying Treatment or Adding Obstacles?

Yang T, Cutshall BT, Tatara A, Ruegger M.

J Pharm Pract. 2019 Aug;32(4):447-449. doi: 10.1177/0897190017753041. Epub 2018 Oct 1.

PMID:
30270723
7.

Immunosuppressed Adult Zebrafish Model of Mucormycosis.

Tatara AM, Wurster S, Lockworth CR, Albert ND, Walsh TJ, Mikos AG, Eisenhoffer GT, Kontoyiannis DP.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00698-18. doi: 10.1128/AAC.00698-18. Print 2018 Nov. No abstract available.

8.

Econazole-releasing porous space maintainers for fungal periprosthetic joint infection.

Tatara AM, Rozich AJ, Kontoyiannis PD, Watson E, Albert ND, Bennett GN, Mikos AG.

J Mater Sci Mater Med. 2018 May 11;29(5):70. doi: 10.1007/s10856-018-6073-1.

9.

Large Animal Models of an In Vivo Bioreactor for Engineering Vascularized Bone.

Akar B, Tatara AM, Sutradhar A, Hsiao HY, Miller M, Cheng MH, Mikos AG, Brey EM.

Tissue Eng Part B Rev. 2018 Aug;24(4):317-325. doi: 10.1089/ten.TEB.2018.0005. Epub 2018 Apr 12.

10.

Invasive Cutaneous Facial Mucormycosis in a Trauma Patient.

Jundt JS, Wong MEK, Tatara AM, Demian NM.

J Oral Maxillofac Surg. 2018 Sep;76(9):1930.e1-1930.e5. doi: 10.1016/j.joms.2018.01.022. Epub 2018 Feb 16.

PMID:
29458027
11.

Drug delivery and tissue engineering to promote wound healing in the immunocompromised host: Current challenges and future directions.

Tatara AM, Kontoyiannis DP, Mikos AG.

Adv Drug Deliv Rev. 2018 Apr;129:319-329. doi: 10.1016/j.addr.2017.12.001. Epub 2017 Dec 6. Review.

12.

Time to Occurrence Based on Risk Stratification of Hospital-Acquired Venous Thromboembolism: A Retrospective Observational Cohort Study.

Tatara AW, Ruegger M, Adeola M, Putney D.

J Pharm Pract. 2017 Jan 1:897190017735423. doi: 10.1177/0897190017735423. [Epub ahead of print]

PMID:
29017425
13.

Synthesis and Characterization of Diol-Based Unsaturated Polyesters: Poly(diol fumarate) and Poly(diol fumarate-co-succinate).

Tatara AM, Watson E, Satish T, Scott DW, Kontoyiannis DP, Engel PS, Mikos AG.

Biomacromolecules. 2017 Jun 12;18(6):1724-1735. doi: 10.1021/acs.biomac.7b00044. Epub 2017 May 17.

PMID:
28486802
14.

Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.

Heo ST, Tatara AM, Jiménez-Ortigosa C, Jiang Y, Lewis RE, Tarrand J, Tverdek F, Albert ND, Verweij PE, Meis JF, Mikos AG, Perlin DS, Kontoyiannis DP.

Clin Infect Dis. 2017 Jul 15;65(2):216-225. doi: 10.1093/cid/cix297.

15.

Effects of Local Antibiotic Delivery from Porous Space Maintainers on Infection Clearance and Induction of an Osteogenic Membrane in an Infected Bone Defect.

Shah SR, Smith BT, Tatara AM, Molina ER, Lee EJ, Piepergerdes TC, Uhrig BA, Guldberg RE, Bennett GN, Wenke JC, Mikos AG.

Tissue Eng Part A. 2017 Feb;23(3-4):91-100. doi: 10.1089/ten.TEA.2016.0389. Epub 2017 Jan 11.

16.

Reconstruction of large mandibular defects using autologous tissues generated from in vivo bioreactors.

Tatara AM, Shah SR, Demian N, Ho T, Shum J, van den Beucken JJJP, Jansen JA, Wong ME, Mikos AG.

Acta Biomater. 2016 Nov;45:72-84. doi: 10.1016/j.actbio.2016.09.013. Epub 2016 Sep 12.

PMID:
27633319
17.

Acellular mineral deposition within injectable, dual-gelling hydrogels for bone tissue engineering.

Vo TN, Tatara AM, Santoro M, van den Beucken JJ, Leeuwenburgh SC, Jansen JA, Mikos AG.

J Biomed Mater Res A. 2017 Jan;105(1):110-117. doi: 10.1002/jbm.a.35875. Epub 2016 Sep 21.

PMID:
27557993
18.

Tissue Engineering in Orthopaedics.

Tatara AM, Mikos AG.

J Bone Joint Surg Am. 2016 Jul 6;98(13):1132-9. doi: 10.2106/JBJS.16.00299. Review.

19.

Factors affecting patient outcome in primary cutaneous aspergillosis.

Tatara AM, Mikos AG, Kontoyiannis DP.

Medicine (Baltimore). 2016 Jun;95(26):e3747. doi: 10.1097/MD.0000000000003747. Review.

20.

Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae.

Bellanger AP, Tatara AM, Shirazi F, Gebremariam T, Albert ND, Lewis RE, Ibrahim AS, Kontoyiannis DP.

J Infect Dis. 2016 Jul 1;214(1):114-21. doi: 10.1093/infdis/jiw090. Epub 2016 Mar 16.

21.

Injectable dual-gelling cell-laden composite hydrogels for bone tissue engineering.

Vo TN, Shah SR, Lu S, Tatara AM, Lee EJ, Roh TT, Tabata Y, Mikos AG.

Biomaterials. 2016 Mar;83:1-11. doi: 10.1016/j.biomaterials.2015.12.026. Epub 2015 Dec 31.

22.

2015 Lifetime Achievement Award of Tissue Engineering and Regenerative Medicine International Society-Americas: Antonios G. Mikos, PhD.

Tatara AM, Mikos AG.

Tissue Eng Part A. 2016 Jan;22(1-2):1-2. doi: 10.1089/ten.tea.2015.29000.agm. Epub 2015 Dec 18. No abstract available.

PMID:
26682734
23.

Atypical antipsychotic properties of AD-6048, a primary metabolite of blonanserin.

Tatara A, Shimizu S, Masui A, Tamura M, Minamimoto S, Mizuguchi Y, Ochiai M, Mizobe Y, Ohno Y.

Pharmacol Biochem Behav. 2015 Nov;138:14-9. doi: 10.1016/j.pbb.2015.09.003. Epub 2015 Sep 9.

PMID:
26363311
24.

Biodegradable, phosphate-containing, dual-gelling macromers for cellular delivery in bone tissue engineering.

Watson BM, Vo TN, Tatara AM, Shah SR, Scott DW, Engel PS, Mikos AG.

Biomaterials. 2015 Oct;67:286-96. doi: 10.1016/j.biomaterials.2015.07.016. Epub 2015 Jul 21.

25.

Hcn1 is a tremorgenic genetic component in a rat model of essential tremor.

Ohno Y, Shimizu S, Tatara A, Imaoku T, Ishii T, Sasa M, Serikawa T, Kuramoto T.

PLoS One. 2015 May 13;10(5):e0123529. doi: 10.1371/journal.pone.0123529. eCollection 2015.

26.

Infected animal models for tissue engineering.

Tatara AM, Shah SR, Livingston CE, Mikos AG.

Methods. 2015 Aug;84:17-24. doi: 10.1016/j.ymeth.2015.03.025. Epub 2015 Apr 2. Review.

27.

Autologously generated tissue-engineered bone flaps for reconstruction of large mandibular defects in an ovine model.

Tatara AM, Kretlow JD, Spicer PP, Lu S, Lam J, Liu W, Cao Y, Liu G, Jackson JD, Yoo JJ, Atala A, van den Beucken JJ, Jansen JA, Kasper FK, Ho T, Demian N, Miller MJ, Wong ME, Mikos AG.

Tissue Eng Part A. 2015 May;21(9-10):1520-8. doi: 10.1089/ten.TEA.2014.0426. Epub 2015 Mar 3.

28.

In vivo bioreactors for mandibular reconstruction.

Tatara AM, Wong ME, Mikos AG.

J Dent Res. 2014 Dec;93(12):1196-202. doi: 10.1177/0022034514547763. Epub 2014 Aug 19. Review.

29.

The role of muscle loading on bone (Re)modeling at the developing enthesis.

Tatara AM, Lipner JH, Das R, Kim HM, Patel N, Ntouvali E, Silva MJ, Thomopoulos S.

PLoS One. 2014 May 21;9(5):e97375. doi: 10.1371/journal.pone.0097375. eCollection 2014.

30.

Use of porous space maintainers in staged mandibular reconstruction.

Henslee AM, Spicer PP, Shah SR, Tatara AM, Kasper FK, Mikos AG, Wong ME.

Oral Maxillofac Surg Clin North Am. 2014 May;26(2):143-9. doi: 10.1016/j.coms.2014.01.002. Review.

PMID:
24794263
31.

Gelatin carriers for drug and cell delivery in tissue engineering.

Santoro M, Tatara AM, Mikos AG.

J Control Release. 2014 Sep 28;190:210-8. doi: 10.1016/j.jconrel.2014.04.014. Epub 2014 Apr 16. Review.

32.

Role of cerebellar dopamine D(3) receptors in modulating exploratory locomotion and cataleptogenicity in rats.

Shimizu S, Tatara A, Sato M, Sugiuchi T, Miyoshi S, Andatsu S, Kizu T, Ohno Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:157-62. doi: 10.1016/j.pnpbp.2013.12.013. Epub 2013 Dec 22.

PMID:
24368396
33.

5-HT1A agonist alleviates serotonergic potentiation of extrapyramidal disorders via postsynaptic mechanisms.

Shimizu S, Mizuguchi Y, Tatara A, Kizu T, Andatsu S, Sobue A, Fujiwara M, Morimoto T, Ohno Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:86-91. doi: 10.1016/j.pnpbp.2013.06.016. Epub 2013 Jul 6.

PMID:
23838274
34.

Region-specific elevation of D₁ receptor-mediated neurotransmission in the nucleus accumbens of SHR, a rat model of attention deficit/hyperactivity disorder.

Ohno Y, Okano M, Masui A, Imaki J, Egawa M, Yoshihara C, Tatara A, Mizuguchi Y, Sasa M, Shimizu S.

Neuropharmacology. 2012 Sep;63(4):547-54. doi: 10.1016/j.neuropharm.2012.04.031. Epub 2012 May 10.

PMID:
22580374
35.

Modulation of antipsychotic-induced extrapyramidal side effects by medications for mood disorders.

Tatara A, Shimizu S, Shin N, Sato M, Sugiuchi T, Imaki J, Ohno Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Aug 7;38(2):252-9. doi: 10.1016/j.pnpbp.2012.04.008. Epub 2012 Apr 17.

PMID:
22542492
36.

Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI.

Johnson PJ, Tatara A, McCreedy DA, Shiu A, Sakiyama-Elbert SE.

Soft Matter. 2010 Oct 21;6(20):5127-5137.

37.

Serotonergic modulation of extrapyramidal motor disorders in mice and rats: role of striatal 5-HT3 and 5-HT6 receptors.

Ohno Y, Imaki J, Mae Y, Takahashi T, Tatara A.

Neuropharmacology. 2011 Feb-Mar;60(2-3):201-8. doi: 10.1016/j.neuropharm.2010.08.019. Epub 2010 Sep 9.

PMID:
20813116
38.

Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist.

Ohno Y, Okano M, Imaki J, Tatara A, Okumura T, Shimizu S.

Pharmacol Biochem Behav. 2010 Aug;96(2):175-80. doi: 10.1016/j.pbb.2010.04.027. Epub 2010 May 10.

PMID:
20460137
39.

Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders.

Shimizu S, Tatara A, Imaki J, Ohno Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):877-81. doi: 10.1016/j.pnpbp.2010.04.005. Epub 2010 Apr 14.

PMID:
20398719
40.
41.

Characterization of phages virulent for Sarothamnus scoparius bradyrhizobia.

Małek W, Sajnaga E, Wdowiak-Wróbel S, Studzińska B, Icka IS, Nosalewicz I, Słomka M, Tatara A, Gawron A.

Curr Microbiol. 2005 Oct;51(4):244-9. Epub 2005 Aug 25.

PMID:
16132456
42.

Staged Fontan procedure for mitral atresia associated with severe tricuspid regurgitation, pulmonary hypertension, and pulmonary artery distortion.

Matsumura Y, Kurosawa H, Morita K, Nomura K, Shimizu S, Tatara A.

Jpn J Thorac Cardiovasc Surg. 2002 Apr;50(4):173-7.

PMID:
11993200
43.

[Midterm results of total aortic root replacement with pulmonary autograft (Ross operation)].

Morita K, Kurosawa H, Sakamoto Y, Koyanagi K, Uno Y, Ishii S, Shimizu S, Tatara A, Sugiyama K, Inoue N.

Kyobu Geka. 2000 Apr;53(4):269-74. Japanese.

PMID:
10770051
44.

[Estimation of left internal thoracic artery flow reserve after coronary artery bypass grafting using Doppler flow wire].

Yoshida S, Goto Y, Sugiura T, Hashimoto K, Ogawa T, Mori C, Sakamoto H, Mikawa H, Seo A, Mochizuki S, Shimizu S, Tatara A, Suzuki K, Okuyama H, Mashiko K, Kurosawa H.

J Cardiol. 1999 Jun;33(6):297-305. Japanese.

PMID:
10396703
45.

[Pulmonary arterial reconstruction with autologous pulmonary arterial tissue for pulmonary artery sling].

Koh Y, Kurosawa H, Morita K, Miyamoto N, Ishii S, Tatara A.

Nihon Kyobu Geka Gakkai Zasshi. 1997 Apr;45(4):572-6. Japanese.

PMID:
9155127
46.

[Mitral valve remodeling using valvuloplasty, chordoplasty and ring annuloplasty].

Nakano M, Kurosawa H, Okuyama H, Nagahori R, Tatara A, Shimizu S.

J Cardiol. 1997;29 Suppl 2:51-6. Japanese.

PMID:
9211103
47.

[A surgical case report--rare association of tetralogy of Fallot with cor triatriatum, unroofed coronary sinus and persistent left superior vena cava].

Nomura K, Kurosawa H, Morita K, Miyamoto H, Tatara A, Hanai M.

Nihon Kyobu Geka Gakkai Zasshi. 1997 Jan;45(1):92-5. Japanese.

PMID:
9028133
48.

[Mitral valve repair for mitral regurgitation--technical contrivance and its further application].

Nakano M, Kurosawa H, Morita K, Nagahori R, Tatara A, Shimizu S.

Nihon Kyobu Geka Gakkai Zasshi. 1995 Sep;43(9):1617-24. Japanese.

PMID:
8530847
49.

[The effect of mitral valve repair and postoperative mitral valve function].

Nakano M, Kurosawa H, Okuyama H, Nagahori R, Tatara A.

Kyobu Geka. 1995 Jul;48(8):666-70. Japanese.

PMID:
7643503
50.

[Autologous fibrin glue from concentrated platelet rich plasma: intraoperative plasma sequestration using autotransfusion device].

Takakura H, Kurosawa H, Mizuno A, Tatara A, Sakamoto Y, Saitoh F.

Rinsho Kyobu Geka. 1994 Jun;14(3):221-3. Japanese.

PMID:
9423095

Supplemental Content

Loading ...
Support Center